Marnie Oakley, DMD
, is an associate professor and associate dean of clinical affairs at the University of Pittsburgh School of Dental Medicine, from which she received her DMD in 1992. Dr. Oakley served in both active duty and reserve roles as a dental officer in the United States Navy. As an experienced educator, she has taught numerous courses related to clinical dentistry, including Oral Diagnosis and Treatment Planning, Clinical Restorative Dentistry, and the Clinical Responsibility course series. In addition to being a published author and presenter on the subject of prescription drug abuse, Dr. Oakley currently serves on the Expert Panel for the Prevention of Prescription Abuse in the Workplace (PAW), a program that works with grantees of the Substance Abuse and Mental Health Services Administration (SAMHSA) to reduce prescription drug abuse in the workplace.
Jean O’Donnell, DMD, MSN, is an associate professor and associate dean for academic affairs at the University of Pittsburgh School of Dental Medicine, from which she received her DMD in 1990. Dr. O’Donnell holds a bachelor’s degree in nursing from Pennsylvania State University and a master’s degree in nursing from the University of Pittsburgh. She is a graduate of the American Dental Education Association (ADEA) Leadership Institute and currently serves as one of the University’s liaisons to the ADEA Commission on Change and Innovation in Dental Education. Dr. O’Donnell is an active member of the Working Group on Interprofessional Education, a multidisciplinary committee representing the health science schools of the University of Pittsburgh. Her primary research interests include prescription drug abuse, tobacco use, and education.
Michael A. Zemaitis, PhD, holds a bachelor’s degree in pharmacy and a PhD in pharmacology. He is a professor in the Department of Pharmaceutical Sciences in the University of Pittsburgh School of Pharmacy, and he teaches in the professional and graduate programs in the School of Pharmacy and the School of Dental Medicine. Dr. Zemaitis’s current area of research interest is biochemical pharmacology, with a special interest in drug and metabolite analysis in biological fluids. He actively supports several pharmacy-related policy issues, including the establishment of a prescription drug monitoring program in the Commonwealth of Pennsylvania designed to reduce drug diversion and abuse, and “Project Life Line,” a program to have community pharmacies provide the narcotic antidote naloxone to high-risk opiate users to prevent overdose deaths.